Detection Time of Oxazepam and Zopiclone in Urine and Oral Fluid after Experimental Oral Dosing.


Journal

Journal of analytical toxicology
ISSN: 1945-2403
Titre abrégé: J Anal Toxicol
Pays: England
ID NLM: 7705085

Informations de publication

Date de publication:
01 Jun 2019
Historique:
received: 27 06 2018
revised: 16 08 2018
pubmed: 8 1 2019
medline: 8 1 2020
entrez: 8 1 2019
Statut: ppublish

Résumé

Data from previous experimental studies on the detection time of oxazepam and zopiclone in biological matrices are limited. The aim of this study was to examine the detection time in urine and oral fluid after single oral doses of oxazepam and zopiclone. Ten healthy volunteers received 25 mg of oxazepam in the evening of Day 1 and 7.5 mg of zopiclone in the evening of Day 3. Urine and oral fluid samples were collected twice daily for 9 days, with an additional sampling the day after ingestion of zopiclone. A total of 19 samples of both urine and oral fluid from each participant were analyzed using fully validated chromatographic methods. The median detection time for oxazepam was 91 h (range 73-108) in urine and 67 h (range 50-98) in oral fluid. The median detection time for zopiclone in urine was 49 h (range 25-98) and 59 h (range 48-146) in oral fluid. The metabolite zopiclone N-oxide showed a detection time of 36 h (range 25-84) in urine. The area under the concentration-time curve (AUCTotal) in urine corrected for creatinine was 150 μmol/L/mmol/L*h (range 105-216) for oxazepam and 1.60 μmol/L/mmol/L*h (range 0.79-4.53) for zopiclone. In oral fluid, the AUCtotal was 673 nmol/L*h (range 339-1,316) for oxazepam and 2,150 nmol/L*h (range 493-4,240) for zopiclone. In conclusion, oxazepam can be detected longer in urine than in oral fluid, while zopiclone can be detected longer in oral fluid than in urine. The high AUCTotal for zopiclone in oral fluid shows that the transfer into oral fluid is significant. In certain individuals the detection time of zopiclone in oral fluid is long. These results can be helpful when interpreting drug testing analyzes.

Identifiants

pubmed: 30615130
pii: 5274652
doi: 10.1093/jat/bky083
doi:

Substances chimiques

Azabicyclo Compounds 0
Piperazines 0
zopiclone 03A5ORL08Q
Oxazepam 6GOW6DWN2A

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

369-377

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Auteurs

Lina Dorthea Bruun (LD)

Department of Forensic Medicine, Oslo University Hospital, Nydalen, Oslo, Norway.

Kari Kjeldstadli (K)

Department of Pharmacology, Oslo University Hospital, Nydalen, Oslo, Norway.

Vidar Temte (V)

Department of Forensic Medicine, Oslo University Hospital, Nydalen, Oslo, Norway.

Morris Birdal (M)

Department of Forensic Medicine, Oslo University Hospital, Nydalen, Oslo, Norway.

Liliana Bachs (L)

Department of Forensic Medicine, Oslo University Hospital, Nydalen, Oslo, Norway.

Marit Langødegård (M)

Department of Forensic Medicine, Oslo University Hospital, Nydalen, Oslo, Norway.

Dag Helge Strand (DH)

Department of Forensic Medicine, Oslo University Hospital, Nydalen, Oslo, Norway.

Kristin Irene Gaare (KI)

Department of Forensic Medicine, Oslo University Hospital, Nydalen, Oslo, Norway.

Elisabeth Øiestad (E)

Department of Forensic Medicine, Oslo University Hospital, Nydalen, Oslo, Norway.
School of Pharmacy, University of Oslo, PO Box 1068, Blindern, Oslo, Norway.

Gudrun Høiseth (G)

Department of Forensic Medicine, Oslo University Hospital, Nydalen, Oslo, Norway.
Diakonhjemmet Hospital, Center for Psychopharmacology, Vinderen, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH